Nagoya, Japan

Masahiko Koketsu

This inventor holds 1 USPTO granted patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiko Koketsu. Retrieved from https://idiyas.com/inventor/masahiko-koketsu-9bblqtqy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiko Koketsu: Innovator in Anti-Tumor Agents

Introduction

Masahiko Koketsu is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-tumor agents. His innovative work has led to the creation of a unique compound that holds promise in cancer treatment.

Latest Patents

Koketsu holds a patent for "Uracil derivatives for use as anti-tumor agents having silicon." This patent describes an organo-silicone compound characterized by a specific formula, where various components such as X, Y, n, and R groups play crucial roles in its functionality. The compound is designed for use as an anti-tumor agent or in anti-tumor compositions, showcasing Koketsu's commitment to advancing cancer therapies. He has 1 patent to his name.

Career Highlights

Throughout his career, Masahiko Koketsu has been associated with Sanwa Kagaku Kenkyusho Co., Ltd., a company known for its research and development in the pharmaceutical sector. His work has been instrumental in pushing the boundaries of what is possible in cancer treatment.

Collaborations

Koketsu has collaborated with esteemed colleagues such as Takahiko Mitani and Masayasu Kurono. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Masahiko Koketsu's contributions to the development of anti-tumor agents highlight his role as a key innovator in medicinal chemistry. His work continues to inspire advancements in cancer treatment and showcases the importance of research in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…